According to Hims & Hers Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.87015. At the end of 2023 the company had a P/S ratio of 2.77.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.77 | 9.55% |
2022 | 2.53 | -48.56% |
2021 | 4.91 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | 24.9 | 1,230.44% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | 31.4 | 1,576.73% | ๐ฌ๐ง UK |
![]() Novavax NVAX | 0.5016 | -73.18% | ๐บ๐ธ USA |
![]() Novocure
NVCR | 3.49 | 86.75% | Jersey |